SCYNEXIS
SCYX
#10457
Rank
โ‚น4.06 B
Marketcap
โ‚น408.41
Share price
-11.72%
Change (1 day)
489.80%
Change (1 year)

Earnings for SCYNEXIS (SCYX)

Earnings in 2026 (TTM): -โ‚น0.96 Billion

According to SCYNEXIS's latest financial reports the company's current earnings are โ‚น19.21 Million. In 2025 the company made an earning of -โ‚น0.82 Billion, an increase over its 2024 earnings that were of -โ‚น1.97 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for SCYNEXIS from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น0.96 Billion16.59%
2025 -โ‚น0.82 Billion-58.45%
2024 -โ‚น1.97 Billion-128.88%
2023 โ‚น6.80 B-212.84%
2022 -โ‚น6.04 Billion87.15%
2021 -โ‚น3.23 Billion-41.74%
2020 -โ‚น5.54 Billion8.41%
2019 -โ‚น5.11 Billion205.58%
2018 -โ‚น1.67 Billion-25.66%
2017 -โ‚น2.25 Billion-31.73%
2016 -โ‚น3.29 Billion19.9%
2015 -โ‚น2.75 Billion111.45%
2014 -โ‚น1.3 Billion-27.82%
2013 -โ‚น1.8 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Galmed Pharmaceuticals
GLMD
-โ‚น1.1 Billion 10.83%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Catalyst Pharmaceuticals
CPRX
โ‚น28.69 B-2,996.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-โ‚น8.81 Billion 789.11%๐Ÿ‡บ๐Ÿ‡ธ USA
KemPharm
KMPH
-โ‚น4.06 Billion 309.39%๐Ÿ‡บ๐Ÿ‡ธ USA